Clinical Trials Directory

Trials / Unknown

UnknownNCT04279717

Latin-American Von Willebrand Disease Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Academia Nacional de Medicina · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Establish a Latin-American network of centers and professionals with the aim of: * To register VWD patients in retrospective/prospective study, using a database, available online, common to all * To register the bleeding history, the treatment and the events of VWD patients in the region * To investigate the influence of VWD on quality of life

Detailed description

von Willebrand disease (VWD) is the most common autosomal bleeding disorder, mostly inherited as dominant trait. VWD is due to deficiency/abnormality of von Willebrand factor (VWF). The prevalence of VWD is unknown, but estimated as 0.1% to 1% of the general population. Although the autosomal inheritance pattern would suggest an equal distribution of male and female patients, the disease is diagnosed in more females because of female-specific hemostatic challenges: menses, ovulation, pregnancy and childbirth. Diagnosis of VWD is made by assessing personal and family history of bleeding, physical examination and completed with specific laboratory tests. There is limited information on the epidemiology of VWD in developing countries. Some countries in Latin America have registries of severe disease that, although it is the rarest form, carries the highest costs for regional health systems. So that the prevalence of clinical symptoms and laboratory features of the disease as well as the management of the disease in Latin America is unknown. The present project aims to establish a network of centers and professionals with the objective to register and investigate all patients with VWD in Latin America, using a database available online common to all, to gain understanding about phenotype, genotype and management of VWD in the region.

Conditions

Interventions

TypeNameDescription
OTHERObservationNo interventions planned: treatment of patients at the discretion of the treating/responsible physician
OTHERObservationNo interventions planned: treatment of patients at the discretion of the treating/responsible physician

Timeline

Start date
2020-02-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2020-02-21
Last updated
2020-02-21

Source: ClinicalTrials.gov record NCT04279717. Inclusion in this directory is not an endorsement.